Research for the Relationship between LncRNAs and Type 2 Diabetes as well as LADA

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025333

Enrollment

Unknown

Registered

2019-08-24

Start date

2017-05-01

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Interventions

LADA group:LADA?

Control group:N/A

T2DM?:T2DM?

Eligibility

Sex/Gender

All

Age

30 Years to 55 Years

Inclusion criteria

Inclusion criteria: Case Group: Confirmed type 2 diabetes or LADA aged 30 to 55; Control Group: Healthy people aged 30-55 years.

Exclusion criteria

Exclusion criteria: Patients with diabetes complications

Design outcomes

Primary

Measure	Time frame
blood glucose;pancreas islets function;	—

Secondary

Measure	Time frame
blood lipid;liver function;kidney function;insulin autoantibody(IAA);islet Cell Antibody (ICA);glutamic acid decarboxylase antibody (GADA);protein tyrosine phosphatase antibody(IA-2A);	—

Countries

China

Contacts

Public ContactHanqing Cai

Second Hospital of Jilin University

caihanqing16@163.com+86 13674315020

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026